Behcet's disease:: An update on the pathogenesis

被引:0
|
作者
Gül, A [1 ]
机构
[1] Univ Istanbul, Fac Med, Div Rheumatol, Dept Internal Med, TR-34390 Istanbul, Turkey
关键词
Behcet's disease; HLA-B51; complex genetic disease; tumor necrosis factor; pathergy; cytokines; heat shock proteins; gamma delta T-cell; vasculitis; endothelial activation; thrombotic tendency;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Behcet's disease is a chronic inflammatory disorder of unknown etiology. It has long been postulated that immunological abnormalities, which are possibly induced by, microbial pathogens in genetically susceptible individuals, are important in its pathogenesis. Recent findings have both supported the significance of genetic factors and better defined the nature of inflammation in Behcet's disease. Molecular genetic studies have strengthened the primary association of HLA-B51 with Behcet's disease. The exact pathogenic mechanism of the HLA-B51 molecule is still unknown, and its contribution to the overall genetic susceptibility to Behcet's disease is estimated to be less than 20%. Spontaneous and/or induced overexpression of pro-inflammatory cytokines (mainly Th1 type)from various cellular sources seems responsible for the enhanced inflammatory reaction in Behcet's disease, and it may be associated with the genetic susceptibility . An antigen-driven immune response superimposed on this primed-state and induced by heat shock proteins or other peptides,from different strains of streptoccocci or other microbial agents has been suggested to trigger manifestations of Behcet's disease. Endothelial activation/injury and the resultant occlusive vasculopathy may also contribute to the tissue damage.
引用
收藏
页码:S6 / S12
页数:7
相关论文
共 50 条
  • [21] Behcet's disease
    Nair, Jagdish R.
    Moots, Robert J.
    CLINICAL MEDICINE, 2017, 17 (01) : 71 - 77
  • [22] A Possible Role for Interleukin 37 in the Pathogenesis of Behcet's Disease
    Ye, Z.
    Wang, C.
    Kijlstra, A.
    Zhou, X.
    Yang, P.
    CURRENT MOLECULAR MEDICINE, 2014, 14 (04) : 535 - 542
  • [23] Behcet’s disease
    S. A. Al-Mutawa
    S. M. Hegab
    Clinical and Experimental Medicine, 2004, 4 : 103 - 131
  • [24] Behcet's disease
    Saadoun, David
    Wechsler, Bertrand
    ORPHANET JOURNAL OF RARE DISEASES, 2012, 7
  • [25] Advances in pathogenesis and treatment of ocular involvement in Behcet's disease
    Lin, Suibin
    Xu, Zhirong
    Lin, Zhiming
    Xie, Baozhao
    Feng, Junmei
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [26] Serum cytokine profiles in Behcet's disease: Is there a role for IL-15 in pathogenesis?
    Curnow, S. J.
    Pryce, K.
    Modi, N.
    Knight, B.
    Graham, E. M.
    Stewart, J. E.
    Fortune, F.
    Stanford, M. R.
    Murray, P. I.
    Wallace, G. R.
    IMMUNOLOGY LETTERS, 2008, 121 (01) : 7 - 12
  • [27] Behcet's disease - Ophthalmological and general aspects part I . Etiology, pathogenesis and diagnostics
    Pleyer, U.
    Hazirolan, D.
    Winterhalter, S.
    Stuebiger, N.
    OPHTHALMOLOGE, 2012, 109 (11): : 1129 - 1141
  • [28] An update on Behcet's syndrome
    Xenitidis, Theodoros
    Henes, Joerg Christoph
    LARYNGO-RHINO-OTOLOGIE, 2024, 103 (05) : 352 - 357
  • [29] Behcet's syndrome
    Yurdakul, Sebahattin
    Yazici, Hasan
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2008, 22 (05): : 793 - 809
  • [30] Ocular Manifestations of Behcet's Disease: An Update on Diagnostic Challenges and Disease Management
    Zajac, Hanna
    Turno-Krecicka, Anna
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (21)